


Beyond Celiac is the leading trusted resource on celiac disease. We are available and qualified to speak to the press on a variety of topics including, but not limited to:
- Celiac disease as a serious genetic autoimmune disease
- Health equity in celiac disease
- Celiac disease patient advocacy and patient stories
- The need for treatments beyond the gluten-free diet
- The latest in celiac disease research/science/drug development
- Non-GI symptoms of celiac disease
- Connection to other autoimmune diseases
- Growth of the gluten-free market, gluten-free labeling
Media Inquiries and Partnerships
If you are a member of the media and want to know more about Beyond Celiac, including our research program, Science Plan, patient stories, and more, please contact Stacy Eaton-Carter at [email protected].
Celiac Disease Facts and Information
Check out the resources below for more information on Beyond Celiac, celiac disease and the gluten-free diet:
About Beyond Celiac
Download Founder Alice Bast’s Headshots
Beyond Celiac Brand Elements/Logos
Download Celiac Disease: The Basics (including the gluten-free diet)
Fast Facts about Celiac Disease
Download Fact vs Fiction: Celiac Disease and the Gluten-Free Diet
Beyond Celiac Science Plan
Voices of Celiac Disease Patient Stories
Recent Beyond Celiac News
Beyond Celiac Announces America’s Largest Virtual Celiac Disease Event to Support a Cure
A powerful mix of advocacy, information and entertainment on tap for the Beyond Celiac Oct. 23rd virtual fundraiser
Beyond Celiac Presents America’s Largest Celiac Disease Virtual Event to Support a Cure
Powerful Mix of Advocacy, Information and Entertainment on Tap for Oct. 23rd Virtual Fundraiser
FDA issues final rule on hydrolyzed and fermented products labeled gluten-free
Yogurt, pickles, sauerkraut and foods that contain soy sauce and malt flavoring have to follow new FDA rules to assure they are safe for those with celiac disease.
Celiac disease drug and implications for lung injury and respiratory distress in COVID-19
The company studying a drug to address leaky gut in celiac disease has received a patent for investigation of the drug’s effectiveness in treating lung disease, including potentially when it occurs in COVID-19.
